Hughes Abigail, Pelligand Ludovic, Andersson Dan I, Mead Andrew
Comparative Biomedical Sciences, Royal Veterinary College, London, United Kingdom.
Clinical Services and Sciences, Royal Veterinary College, London, United Kingdom.
PLoS One. 2025 Jun 24;20(6):e0327115. doi: 10.1371/journal.pone.0327115. eCollection 2025.
Antimicrobial resistance is a global threat to both human and animal health, and transfer of resistance between these spheres is recognised as a key concern for all species. Selection for resistance at sub-inhibitory antimicrobial concentrations has been characterised for some bacteria-antimicrobial combinations but there is little data from non-laboratory strains, and veterinary antimicrobials and bacterial species. Here, we demonstrate a minimum selective concentration of 0.06 mg/L (1/6 xMIC) for florfenicol in wild-type Pasteurella multocida, through competition experiments between a susceptible strain and a floR-resistant mutant. We also show that sub-inhibitory concentrations of florfenicol do not appear to significantly select for de novo resistance in P. multocida and present the challenges with adapting experimental protocols between bacterial species. These results have important implications for antimicrobial resistance selection at sub-inhibitory concentrations, method development for within-species differentiation in novel bacterial species, and application to policy regarding antimicrobial contamination in animal-feed.
抗菌药物耐药性是对人类和动物健康的全球性威胁,这些领域之间的耐药性转移被认为是所有物种的关键关注点。对于一些细菌-抗菌药物组合,已对亚抑制性抗菌药物浓度下的耐药性选择进行了表征,但来自非实验室菌株、兽用抗菌药物和细菌物种的数据很少。在此,我们通过敏感菌株与氟苯尼考耐药突变体之间的竞争实验,证明了野生型多杀巴斯德菌中氟苯尼考的最低选择浓度为0.06 mg/L(1/6 xMIC)。我们还表明,氟苯尼考的亚抑制浓度似乎不会显著选择多杀巴斯德菌中的从头耐药性,并提出了在不同细菌物种之间调整实验方案的挑战。这些结果对于亚抑制浓度下的抗菌药物耐药性选择、新细菌物种内物种分化的方法开发以及动物饲料中抗菌药物污染政策的应用具有重要意义。